Further Cost Containment To Come

BMI View: The Italian pharmaceutical market continues to be a challenging proposition and BMI believes the sector will be a target of further cost containment in 2012, particularly as National Health System (SSN) data for H111 shows a decline in spending and highlights the success of previous cost-containment efforts.

To read the full article, please choose one of the following options: